The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gramicidin, also called gramicidin D, is a mix of ionophoric antibiotics, gramicidin A, B and C, which make up about 80%, 5%, and 15% of the mix, respectively
Global Gramicidin market is projected to reach US$ 443.5 million in 2029, increasing from US$ 337 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gramicidin market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gramicidin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch and Lomb
Amring Pharma
AbbVie
Bimeda
Bristol Myers Squibb
Dow Pharma
ERFA Canada
Euro Pharm
IPharma
Johnson and Johnson
Odan Laboratories
Pfizer
Sifi
Segment by Type
Liquid
Ointment
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gramicidin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Gramicidin, also called gramicidin D, is a mix of ionophoric antibiotics, gramicidin A, B and C, which make up about 80%, 5%, and 15% of the mix, respectively
Global Gramicidin market is projected to reach US$ 443.5 million in 2029, increasing from US$ 337 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gramicidin market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gramicidin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch and Lomb
Amring Pharma
AbbVie
Bimeda
Bristol Myers Squibb
Dow Pharma
ERFA Canada
Euro Pharm
IPharma
Johnson and Johnson
Odan Laboratories
Pfizer
Sifi
Segment by Type
Liquid
Ointment
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gramicidin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Gramicidin Market Overview
1.1 Product Overview and Scope of Gramicidin
1.2 Gramicidin Segment by Type
1.2.1 Global Gramicidin Market Value Comparison by Type (2023-2029)
1.2.2 Liquid
1.2.3 Ointment
1.3 Gramicidin Segment by Application
1.3.1 Global Gramicidin Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gramicidin Market Size Estimates and Forecasts
1.4.1 Global Gramicidin Revenue 2018-2029
1.4.2 Global Gramicidin Sales 2018-2029
1.4.3 Global Gramicidin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gramicidin Market Competition by Manufacturers
2.1 Global Gramicidin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gramicidin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gramicidin Average Price by Manufacturers (2018-2023)
2.4 Global Gramicidin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gramicidin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gramicidin, Product Type & Application
2.7 Gramicidin Market Competitive Situation and Trends
2.7.1 Gramicidin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gramicidin Players Market Share by Revenue
2.7.3 Global Gramicidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gramicidin Retrospective Market Scenario by Region
3.1 Global Gramicidin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gramicidin Global Gramicidin Sales by Region: 2018-2029
3.2.1 Global Gramicidin Sales by Region: 2018-2023
3.2.2 Global Gramicidin Sales by Region: 2024-2029
3.3 Global Gramicidin Global Gramicidin Revenue by Region: 2018-2029
3.3.1 Global Gramicidin Revenue by Region: 2018-2023
3.3.2 Global Gramicidin Revenue by Region: 2024-2029
3.4 North America Gramicidin Market Facts & Figures by Country
3.4.1 North America Gramicidin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gramicidin Sales by Country (2018-2029)
3.4.3 North America Gramicidin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gramicidin Market Facts & Figures by Country
3.5.1 Europe Gramicidin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gramicidin Sales by Country (2018-2029)
3.5.3 Europe Gramicidin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gramicidin Market Facts & Figures by Country
3.6.1 Asia Pacific Gramicidin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gramicidin Sales by Country (2018-2029)
3.6.3 Asia Pacific Gramicidin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gramicidin Market Facts & Figures by Country
3.7.1 Latin America Gramicidin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gramicidin Sales by Country (2018-2029)
3.7.3 Latin America Gramicidin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gramicidin Market Facts & Figures by Country
3.8.1 Middle East and Africa Gramicidin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gramicidin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gramicidin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gramicidin Sales by Type (2018-2029)
4.1.1 Global Gramicidin Sales by Type (2018-2023)
4.1.2 Global Gramicidin Sales by Type (2024-2029)
4.1.3 Global Gramicidin Sales Market Share by Type (2018-2029)
4.2 Global Gramicidin Revenue by Type (2018-2029)
4.2.1 Global Gramicidin Revenue by Type (2018-2023)
4.2.2 Global Gramicidin Revenue by Type (2024-2029)
4.2.3 Global Gramicidin Revenue Market Share by Type (2018-2029)
4.3 Global Gramicidin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gramicidin Sales by Application (2018-2029)
5.1.1 Global Gramicidin Sales by Application (2018-2023)
5.1.2 Global Gramicidin Sales by Application (2024-2029)
5.1.3 Global Gramicidin Sales Market Share by Application (2018-2029)
5.2 Global Gramicidin Revenue by Application (2018-2029)
5.2.1 Global Gramicidin Revenue by Application (2018-2023)
5.2.2 Global Gramicidin Revenue by Application (2024-2029)
5.2.3 Global Gramicidin Revenue Market Share by Application (2018-2029)
5.3 Global Gramicidin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bausch and Lomb
6.1.1 Bausch and Lomb Corporation Information
6.1.2 Bausch and Lomb Description and Business Overview
6.1.3 Bausch and Lomb Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bausch and Lomb Gramicidin Product Portfolio
6.1.5 Bausch and Lomb Recent Developments/Updates
6.2 Amring Pharma
6.2.1 Amring Pharma Corporation Information
6.2.2 Amring Pharma Description and Business Overview
6.2.3 Amring Pharma Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amring Pharma Gramicidin Product Portfolio
6.2.5 Amring Pharma Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AbbVie Gramicidin Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Bimeda
6.4.1 Bimeda Corporation Information
6.4.2 Bimeda Description and Business Overview
6.4.3 Bimeda Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bimeda Gramicidin Product Portfolio
6.4.5 Bimeda Recent Developments/Updates
6.5 Bristol Myers Squibb
6.5.1 Bristol Myers Squibb Corporation Information
6.5.2 Bristol Myers Squibb Description and Business Overview
6.5.3 Bristol Myers Squibb Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bristol Myers Squibb Gramicidin Product Portfolio
6.5.5 Bristol Myers Squibb Recent Developments/Updates
6.6 Dow Pharma
6.6.1 Dow Pharma Corporation Information
6.6.2 Dow Pharma Description and Business Overview
6.6.3 Dow Pharma Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dow Pharma Gramicidin Product Portfolio
6.6.5 Dow Pharma Recent Developments/Updates
6.7 ERFA Canada
6.6.1 ERFA Canada Corporation Information
6.6.2 ERFA Canada Description and Business Overview
6.6.3 ERFA Canada Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ERFA Canada Gramicidin Product Portfolio
6.7.5 ERFA Canada Recent Developments/Updates
6.8 Euro Pharm
6.8.1 Euro Pharm Corporation Information
6.8.2 Euro Pharm Description and Business Overview
6.8.3 Euro Pharm Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Euro Pharm Gramicidin Product Portfolio
6.8.5 Euro Pharm Recent Developments/Updates
6.9 IPharma
6.9.1 IPharma Corporation Information
6.9.2 IPharma Description and Business Overview
6.9.3 IPharma Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 IPharma Gramicidin Product Portfolio
6.9.5 IPharma Recent Developments/Updates
6.10 Johnson and Johnson
6.10.1 Johnson and Johnson Corporation Information
6.10.2 Johnson and Johnson Description and Business Overview
6.10.3 Johnson and Johnson Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Johnson and Johnson Gramicidin Product Portfolio
6.10.5 Johnson and Johnson Recent Developments/Updates
6.11 Odan Laboratories
6.11.1 Odan Laboratories Corporation Information
6.11.2 Odan Laboratories Gramicidin Description and Business Overview
6.11.3 Odan Laboratories Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Odan Laboratories Gramicidin Product Portfolio
6.11.5 Odan Laboratories Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Gramicidin Description and Business Overview
6.12.3 Pfizer Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Gramicidin Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Sifi
6.13.1 Sifi Corporation Information
6.13.2 Sifi Gramicidin Description and Business Overview
6.13.3 Sifi Gramicidin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sifi Gramicidin Product Portfolio
6.13.5 Sifi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gramicidin Industry Chain Analysis
7.2 Gramicidin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gramicidin Production Mode & Process
7.4 Gramicidin Sales and Marketing
7.4.1 Gramicidin Sales Channels
7.4.2 Gramicidin Distributors
7.5 Gramicidin Customers
8 Gramicidin Market Dynamics
8.1 Gramicidin Industry Trends
8.2 Gramicidin Market Drivers
8.3 Gramicidin Market Challenges
8.4 Gramicidin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
